A new vaccine which induces T Cell immunity, currently known as CoVac-1, could provide long-lasting protection against Covid-19.
The treatment, which is going through trials in Germany, could provide broad immunity with just a single dose.
Tübingen University Hospital Professor Juliane Walz spoke to Susie Ferguson.
